Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications
Nanotechnology has received widespread attention in the last several decades due to the technological breakthroughs it has enabled across sectors from electronics to medicine. Towards the great challenges that nanotechnology arise...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RYC2021-033294-I
Design of Supramolecular Peptide Assemblies for Nanomedical...
236K€
Cerrado
PTQ2018-009872
Investigación de nanopartículas funcionalizadas con un polím...
70K€
Cerrado
RYC-2017-23457
Nanochemistry toward next generation nanomedicines
309K€
Cerrado
BIO2013-41019-P
INGENIERIA DE NANOPARTICULAS PROTEICAS PARA LA ENTREGA DIRIG...
151K€
Cerrado
EEBB-I-12-04913
NANOGELES Y NANOPARTICULAS BLANDAS PARA APLICACIONES BIOTECN...
7K€
Cerrado
MAT2014-57429-R
ESTRATEGIAS DE HIBRIDACION POLIMERO-NANOPARTICULA PARA EL DE...
61K€
Cerrado
Información proyecto Nano-OligoMed
Duración del proyecto: 60 meses
Fecha Inicio: 2017-11-09
Fecha Fin: 2022-11-30
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Nanotechnology has received widespread attention in the last several decades due to the technological breakthroughs it has enabled across sectors from electronics to medicine. Towards the great challenges that nanotechnology arise, Nano-OligoMed has the ambition to establish and support a network of international collaboration, enabling a collaborative scientific team to effectively use a diversity of approaches and strategies to generate and test hybrid nanomaterials for the efficient and safe systemic delivery of oligonucleotide-based therapeutic agents. To this end, we have set-up a joint multidisciplinary scientific collaborative programme that through exchange, international mobility, and strongly collaborative transfer of knowledge and training activities between 4 European and 3 extra-European countries, will bring together leading experts under the field of nanomaterials in biomedicine. The scientific aim of Nano-OligoMed is the creation of degradable hybrid structures that combine the rigid, inert silica with the delicate programmable oligonucleotides or artificial oligonucleotide-mimics. The possibility to develop novel oligonucleotide-based materials will enable a) the degradation of the drug carrier at the presence of a specific input as a function of the intrinsic bio-responsive feature of oligonucleotides, b) the activation of a therapeutic function as a result of the bio-molecular interaction between the oligonucleotide-based material and the molecular target (i.e. miRNAs) and c) the delivery of the chemical payload (DNA and/or artificial mimics, even in combination with cancer drugs) upon cell internalization. The international academic networking, the broadening of the research skills, the educational activities, will provide to young (PhD students) and senior scientists, specific competences in the field of materials sciences, nanotechnology, molecular biology and molecular medicine.